Viking Thera (VKTX): Congress and insider trades
Who in Congress and inside the company traded VKTX, when each filing appeared, and what buying after each one would have earned against the S&P 500.
Key Facts
- Viking Thera (VKTX) is a listed stock on NASDAQ.
- Insiders filed 1 open market buy worth $150K and 3 sells worth $6.3M, the latest filed 2026-07-29 (29 July 2026).
- Across 1 scored buy, Insiders averaged -27.5% against the S&P 500 (SPY) over the 90 days after disclosure, with 0% of them ahead of the index. That result is too few trades to tell.
- Data as of 2026-09-29 (29 September 2026).
Insider trades in VKTX
as of 2026-07-29| Filed | Insider | Type | Shares | Price | Value | 90 day vs S&P |
|---|---|---|---|---|---|---|
| 29 Jul 2026 | Lian Brian | sell | 148,517 | $33.32 | $4.9M | n/a |
| 29 Jul 2026 | ZANTE GREG | sell | 21,217 | $33.47 | $710K | n/a |
| 29 Jul 2026 | Mancini Marianna | sell | 18,217 | $33.47 | $610K | n/a |
| 10 Mar 2026 | Aubuchon Neil William | buy | 4,475 | $33.50 | $150K | -27.5% |
Nothing matches that search.
Related pages
Frequently asked questions
Who has bought VKTX?
0 Congress buys by 0 members and 1 insider buy are on file. The tables on this page list every one.
Did buying VKTX after a disclosure beat the market?
Across 1 scored buy, Insiders averaged -27.5% against the S&P 500 (SPY) over the 90 days after disclosure, with 0% of them ahead of the index. That result is too few trades to tell. A single stock is a small sample.
Sources: Congressional trades: STOCK Act disclosures, collected from CapitolTrades. Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.
Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.